Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
18%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
PPH
27
HOLDINGS
54%
ALSO IN XPH
XPH
47
HOLDINGS
28%
ALSO IN PPH
SECTOR DRIFT (PPH minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
| JOHNSON & JOHNSON | 4.8% | 2.8% | 2.8% | |
| ELI LILLY & CO | 20.5% | 2.7% | 2.7% | |
| MERCK & CO. INC. | 7.4% | 2.6% | 2.6% | |
| PFIZER INC | 4.8% | 2.6% | 2.6% | |
| ZOETIS INC | 4.2% | 2.5% | 2.5% | |
PPH Overweight Relative to XPH
| ELI LILLY & CO | 17.8% | |
| NOVARTIS AG-ADR | 9.8% | |
| NOVO-NORDISK A/S-SPONS ADR | 7.4% | |
| MCKESSON CORP | 4.8% | |
| MERCK & CO. INC. | 4.8% | |
| ABBVIE INC | 4.7% | |
| GLAXOSMITHKLINE PLC-SPON ADR | 4.7% | |
| SANOFI-AVENTIS-ADR | 4.7% | |
| ASTRAZENECA PLC-SPONS ADR | 4.6% | |
| CENCORA INC | 3.8% |
PPH Underweight Relative to XPH
| TARSUS PHARMACEUTICALS, INC. | -3.4% | |
| CRINETICS PHARMACEUTICALS INC | -3.0% | |
| LIGAND PHARMACEUTICALS-CL B | -2.8% | |
| SUPERNUS PHARMACEUTICALS INC | -2.8% | |
| ROYALTY PHARMA PLC CLASS A | -2.6% | |
| ELANCO ANIMAL HEALTH, INC. | -2.5% | |
| BIOSANTE PHARMACEUTICALS INC | -2.5% | |
| PRESTIGE BRANDS HOLDINGS INC | -2.4% | |
| CORCEPT THERAPEUTICS INC | -2.4% | |
| PERRIGO CO | -2.4% |